PhaseBio
PhaseBio is a biopharmaceutical firm that researches and develops novel therapeutics for the treatment of orphan diseases.
Business Model:
Revenue: $610k
Employees: 51-200
Industries / Tags:
Detailed PhaseBio Information
Geographic Data
Address: 1 Great Valley Parkway
City: Malvern
State: PA
Zip: 19355
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$64M
Raised Total:$204M
Social
Metrics
837,234Website Global Rank
44,127Website Monthly Traffic
Twitter Followers
Description
PhaseBio is a biopharmaceutical firm that researches and develops novel therapeutics for the treatment of orphan diseases.
Contact Phone:
+16109816500
Contact Email:
PhaseBio went public on 10/17/2018 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
10/17/2018
IPO Valuation:
$119M
Ticker Symbol:
PHAS
IPO Price:
$5/share
Amount Raised:
$46M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
